The 17th Advancing Women's Leadership in Pharma & Healthcare Conference is set to be held on August 27–28, 2026, at the Sonesta Philadelphia Rittenhouse Hotel in Philadelphia, Pennsylvania. Organized by Dynamic Global Events (DGE), the conference aims to empower women and allies across the pharmaceutical, biotechnology, healthcare, and life sciences industries. This event provides a collaborative forum where emerging and established professionals can exchange ideas, build connections, and gain insights from industry leaders.
The conference agenda will feature sessions on mentorship and leadership development, with keynotes and panels led by senior executives from top organizations. Attendees will have the opportunity to participate in workshops designed to enhance career growth and foster inclusive workplace cultures. The event is particularly timely as the healthcare and pharmaceutical sectors continue to emphasize diversity and inclusion as drivers of innovation and business success.
Philadelphia, a major hub for life sciences and healthcare, provides an ideal backdrop for this conference. The city is home to numerous pharmaceutical companies, research institutions, and healthcare organizations, making it a strategic location for networking and collaboration. The Sonesta Philadelphia Rittenhouse Hotel, located in the heart of the city, offers a convenient and inspiring venue for attendees.
For more information about the conference, including registration details and the full agenda, visit https://ibn.fm/3s99n. The event is expected to attract a diverse group of professionals, from early-career individuals to seasoned leaders, all committed to advancing women's leadership in the industry.
InvestorWire, a specialized communications platform, is covering the event as part of its commitment to providing actionable information to the investment community. InvestorWire is one of over 75 brands within the Dynamic Brand Portfolio @IBN, offering services such as wire-grade press release syndication, article syndication to over 5,000 outlets, enhanced press release distribution, social media distribution, and tailored corporate communications solutions. For more information about InvestorWire, visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
